BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17062432)

  • 21. Expression of pleiotrophin, an embryonic growth and differentiation factor, in rheumatoid arthritis.
    Pufe T; Bartscher M; Petersen W; Tillmann B; Mentlein R
    Arthritis Rheum; 2003 Mar; 48(3):660-7. PubMed ID: 12632418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis.
    Guiducci S; Del Rosso A; Cinelli M; Perfetto F; Livi R; Rossi A; Gabrielli A; Giacomelli R; Iori N; Fibbi G; Del Rosso M; Cerinic MM
    Arthritis Res Ther; 2005; 7(6):R1244-53. PubMed ID: 16277677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low level light effects on inflammatory cytokine production by rheumatoid arthritis synoviocytes.
    Yamaura M; Yao M; Yaroslavsky I; Cohen R; Smotrich M; Kochevar IE
    Lasers Surg Med; 2009 Apr; 41(4):282-90. PubMed ID: 19347944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblast-like synoviocytes from patients with rheumatoid arthritis.
    Yokota K; Miyazaki T; Hirano M; Akiyama Y; Mimura T
    J Rheumatol; 2006 Mar; 33(3):463-71. PubMed ID: 16511915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional expression of the chemokine receptor CCR7 on fibroblast-like synoviocytes.
    Brühl H; Mack M; Niedermeier M; Lochbaum D; Schölmerich J; Straub RH
    Rheumatology (Oxford); 2008 Dec; 47(12):1771-4. PubMed ID: 18838387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RhoA-mediated, tumor necrosis factor alpha-induced activation of NF-kappaB in rheumatoid synoviocytes: inhibitory effect of simvastatin.
    Xu H; Liu P; Liang L; Danesh FR; Yang X; Ye Y; Zhan Z; Yu X; Peng H; Sun L
    Arthritis Rheum; 2006 Nov; 54(11):3441-51. PubMed ID: 17075836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolactin locally produced by synovium infiltrating T lymphocytes induces excessive synovial cell functions in patients with rheumatoid arthritis.
    Nagafuchi H; Suzuki N; Kaneko A; Asai T; Sakane T
    J Rheumatol; 1999 Sep; 26(9):1890-900. PubMed ID: 10493666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts.
    Ahmed S; Pakozdi A; Koch AE
    Arthritis Rheum; 2006 Aug; 54(8):2393-401. PubMed ID: 16869002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis.
    Fraser A; Fearon U; Reece R; Emery P; Veale DJ
    Arthritis Rheum; 2001 Sep; 44(9):2024-8. PubMed ID: 11592363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superoxide production and NADPH oxidase expression in human rheumatoid synovial cells: regulation by interleukin-1beta and tumour necrosis factor-alpha.
    Chenevier-Gobeaux C; Lemarechal H; Bonnefont-Rousselot D; Poiraudeau S; Ekindjian OG; Borderie D
    Inflamm Res; 2006 Nov; 55(11):483-90. PubMed ID: 17122966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of interleukin-4 on vascular endothelial growth factor production in rheumatoid synovial fibroblasts.
    Hong KH; Cho ML; Min SY; Shin YJ; Yoo SA; Choi JJ; Kim WU; Song SW; Cho CS
    Clin Exp Immunol; 2007 Mar; 147(3):573-9. PubMed ID: 17302909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating tumour necrosis factor-alpha bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response.
    Marotte H; Maslinski W; Miossec P
    Arthritis Res Ther; 2005; 7(1):R149-55. PubMed ID: 15642135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-1beta induced activation of nuclear factor-kappab can be inhibited by novel pharmacological agents in osteoarthritis.
    Lauder SN; Carty SM; Carpenter CE; Hill RJ; Talamas F; Bondeson J; Brennan P; Williams AS
    Rheumatology (Oxford); 2007 May; 46(5):752-8. PubMed ID: 17218328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines.
    Chabaud M; Fossiez F; Taupin JL; Miossec P
    J Immunol; 1998 Jul; 161(1):409-14. PubMed ID: 9647250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways.
    Amin MA; Mansfield PJ; Pakozdi A; Campbell PL; Ahmed S; Martinez RJ; Koch AE
    Arthritis Rheum; 2007 Jun; 56(6):1787-97. PubMed ID: 17530707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased phosphorylation of ezrin is associated with the migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis.
    Xiao Y; Sun M; Zhan Z; Ye Y; Huang M; Zou Y; Liang L; Yang X; Xu H
    Rheumatology (Oxford); 2014 Jul; 53(7):1291-300. PubMed ID: 24599913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble Fas ligand inhibits angiogenesis in rheumatoid arthritis.
    Kim WU; Kwok SK; Hong KH; Yoo SA; Kong JS; Choe J; Cho CS
    Arthritis Res Ther; 2007; 9(2):R42. PubMed ID: 17459170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between the level of circulating bioactive tumor necrosis factor alpha and the tumor necrosis factor alpha gene polymorphism at -308 in patients with rheumatoid arthritis treated with a tumor necrosis factor alpha inhibitor.
    Marotte H; Arnaud B; Diasparra J; Zrioual S; Miossec P
    Arthritis Rheum; 2008 May; 58(5):1258-63. PubMed ID: 18438841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
    Vandooren B; Kruithof E; Yu DT; Rihl M; Gu J; De Rycke L; Van Den Bosch F; Veys EM; De Keyser F; Baeten D
    Arthritis Rheum; 2004 Sep; 50(9):2942-53. PubMed ID: 15457463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis.
    Nagashima M; Asano G; Yoshino S
    J Rheumatol; 2000 Oct; 27(10):2339-42. PubMed ID: 11036826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.